Compositions and methods for the treatment of primary biliary cholangitis

NZ835893APending Publication Date: 2026-08-28GENFIT SA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
NZ835893
Authority / Receiving Office
NZ · NZ
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-08-26
Filing Date
2021-08-25
Publication Date
2026-08-28

Smart Images

  • Figure 00000028_0000
    Figure 00000028_0000
  • Figure 00000029_0000
    Figure 00000029_0000
Patent Text Reader

Abstract

The invention relates to a pharmaceutical composition comprising elafibranor or a pharmaceutically acceptable salt thereof, for use to treat primary biliary cholangitis (PBC) in a subject intolerant to ursodeoxycholic acid (UDCA).
Need to check novelty before this filing date? Find Prior Art